Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
DMSZX vs BIB
Shared holdings
5
DMSZX covered by BIB
2.82%
BIB covered by DMSZX
2.82%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
DMSZX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| JPMORGAN STRATEGIC INCOME OPPORTUNITIES FUND CL R6 0.00000000 | 19.68% | |
| Franklin Systematic Style Premia ETF | 6.12% | |
| Honda Auto Receivables Owner Trust, Series 2026-1, Class A2A | 3.69% | |
| US ULTRA BOND CBT Sep25 | 2.36% | |
| XENON PHARMACEUTICALS INC | 2.35% | |
| JPMBB COMMERCIAL MORTGAGE SECURITIES TRUST 2015-C32 SER 2015-C32 CL AS REGD 3.98440000 | 2.21% | |
| WORLD OMNI AUTO RECEIVABLES TRUST 2025-D SER 2025-D CL A2A REGD 3.91000000 | 2.11% | |
| WFCM 2017-RB1 A5 | 2.10% | |
| Fannie Mae Connecticut Avenue Securities | 2.09% | |
| CSAIL Commercial Mortgage Trust, Series 2017-CX10, Class AS | 1.98% | |
| FREDDIE MAC STACR TRUST 2019-FTR1 SER 2019-FTR1 CL B2 V/R REGD 144A P/P 12.53628000 | 1.83% | |
| STACR 2020-DNA1 B2 144A FRN 01-25-50 | 1.61% | |
| Citigroup Commercial Mortgage Trust, Series 2015-GC35, Class AS | 1.47% | |
| STACR TRUST 2018-HRP1 SER 2018-HRP1 CL B2 V/R REGD 144A P/P 15.93628000 | 1.45% | |
| STACR 2019-DNA3 B2 | 1.45% | |
| HILLMAN SOLUTIONS CORP | 1.43% | |
| K&F Growth Acquisition Corp II SHS CL A | 1.40% | |
| Oaktree Acquisition Corp. III Life Sciences SHS CL A | 1.34% | |
| FREDDIE MAC STACR TRUST 2019-DNA4 SER 2019-DNA4 CL B2 V/R REGD 144A P/P 10.43628000 | 1.34% | |
| JEFFERSON CAPITAL INC | 1.32% | |
| Anchorage Capital CLO 18 Ltd., Series 2021-18A, Class A1 | 1.32% | |
| Bold Eagle Acquisition Corp CL A | 1.32% | |
| WILLSCOT MOBILE MINI HOLDINGS CORP | 1.30% | |
| FREDDIE MAC STACR TRUST 2019-HQA1 SER 2019-HQA1 CL B2 V/R REGD 144A P/P 16.43628000 | 1.29% | |
| FNMA Connecticut Avenue Securities Trust, Series 2016-C06, Class 1B | 1.27% | |
| CITIGROUP COMMERCIAL MORTGAGE TRUST 2017-P8 SER 2017-P8 CL AS V/R REGD 3.78900000 | 1.25% | |
| GXO LOGISTICS INC | 1.21% | |
| FREDDIE MAC STACR DEBT NOTES 2017-HQA3 SER 2017-HQA3 CL B1 V/R REGD 8.63628000 | 1.20% | |
| Archimedes Tech SPAC Partners II Co. ORD SHS | 1.13% | |
| FREMONT HOME LOAN TRUST 2003-A SER 2003-A CL M1 V/R REGD 5.04376000 | 0.94% | |
| CANNAE HOLDINGS INC | 0.94% | |
| FNMA Connecticut Avenue Securities Trust, Series 2016-C02, Class 1B | 0.90% | |
| BLUE FOUNDRY BANCORP | 0.89% | |
| FREDDIE MAC STACR TRUST 2019-HRP1 SER 2019-HRP1 CL B1 V/R REGD 144A P/P 8.23628000 | 0.89% | |
| Highview Merger Corp. ORD SH CL A | 0.89% | |
| ASSET BACKED FUNDING CERTIFICA ABFC 2003 OPT1 A3 | 0.84% | |
| PARK PLACE SECURITIES INC PPSI 2005 WCH1 M5 | 0.84% | |
| WFRBS Commercial Mortgage Trust, Series 2014-C22, Class AS | 0.82% | |
| SG COMMERCIAL MORTGAGE SECURITIES TRUST 2016-C5 SER 2016-C5 CL AM REGD 3.37900000 | 0.78% | |
| STACR TRUST 2018-HRP1 SER 2018-HRP1 CL B1 V/R REGD 144A P/P 7.93628000 | 0.76% | |
| NewHold Investment Corp. III ORD SHS CL A | 0.73% | |
| DEUTSCHE ALT-A SECURITIES MORTGAGE LOAN TRUST SERI SER 2007-OA5 CL A1A V/R REGD 4.46876000 | 0.72% | |
| Legato Merger Corp. IV | 0.68% | |
| PENN ENTERTAINMENT INC | 0.67% | |
| Willow Lane Acquisition Corp. ORD SHS CL A | 0.63% | |
| TERWIN MORTGAGE TRUST TMTS 2006 7 1A2C 144A | 0.61% | |
| STRUCTURED ASSET INVESTMENT LO SAIL 2004 2 A4 | 0.60% | |
| Gesher Acquisition Corporation II USD CL A ORD SHS | 0.58% | |
| OneIM Acquisition Corp. | 0.56% | |
| Daedalus Special Acquisition Corp. UNIT EXP 111030 | 0.55% |
BIB (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 19.64% | |
| GILEAD SCIENCES INC | 6.95% | |
| VERTEX PHARMACEUTICALS INC | 6.72% | |
| AMGEN INC | 6.59% | |
| Repurchase Agreement | 6.10% | |
| REGENERON PHARMACEUTICALS INC | 4.36% | |
| ALNYLAM PHARMACEUTICALS INC | 2.37% | |
| Invesco Government & Agency Portfolio, Institutional Class | 1.94% | |
| INSMED INC | 1.72% | |
| BIOGEN INC | 1.52% | |
| ARGENX SE SPONSORED ADR | 1.20% | |
| UNITED THERAPEUTICS CORP DEL | 1.17% | |
| MODERNA INC | 1.13% | |
| ILLUMINA INC | 1.11% | |
| ROIVANT SCIENCES LTD | 1.09% | |
| INCYTE CORP | 1.07% | |
| ROYALTY PHARMA PLC | 1.07% | |
| REVOLUTION MEDICINES INC | 1.06% | |
| VIATRIS INC | 0.93% | |
| Ascendis Pharma A/S | 0.77% | |
| NEUROCRINE BIOSCIENCES INC | 0.71% | |
| IONIS PHARMACEUTICALS INC | 0.71% | |
| SANOFI SPON ADR | 0.69% | |
| BRIDGEBIO PHARMA INC | 0.69% | |
| MEDPACE HOLDINGS INC | 0.69% | |
| SUMMIT THERAPEUTICS INC | 0.67% | |
| GUARDANT HEALTH INC | 0.66% | |
| BIOMARIN PHARMACEUTICAL INC | 0.64% | |
| EXELIXIS INC | 0.64% | |
| JAZZ PHARMA PLC | 0.62% | |
| BIONTECH SE ADR | 0.60% | |
| BEONE MEDICINES LTD ADR | 0.54% | |
| MADRIGAL PHARMACEUTICALS INC | 0.53% | |
| IMMUNITYBIO INC | 0.52% | |
| TEMPUS AI INC-A | 0.50% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.46% | |
| PRAXIS PRECISION MEDICINES INC | 0.45% | |
| AXSOME THERAPEUTICS INC | 0.45% | |
| HALOZYME THERAPEUTICS INC | 0.44% | |
| VAXCYTE INC | 0.44% | |
| KRYSTAL BIOTECH INC | 0.43% | |
| CYTOKINETICS INC | 0.41% | |
| NUVALENT INC-A | 0.40% | |
| Abivax SA SPONSORED ADS | 0.39% | |
| ARCELLX INC | 0.36% | |
| KYMERA THERAPEUTICS INC | 0.35% | |
| RHYTHM PHARMACEUTICALS INC | 0.33% | |
| COGENT BIOSCIENCES INC | 0.32% | |
| PROTAGONIST THERAPEUTICS INC | 0.31% | |
| CRISPR THERAPEUTICS AG | 0.31% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.